Pharma giant AstraZeneca has signed a mulitmillion dollar FAO deal with Indian outsourcer Genpact, to manage its finance and accounting systems and processes.

As part of the five year deal, Genpact will work to improve AstraZeneca’s SAP-based accountancy processes whilst reducing cut costs. The company will address processes relating to procure-to-pay, record-to-report and order-to-cash functions.

Graham Russell, head of global transactional finance at AstraZeneca, said that streamlining business processes would enable the company “to improve the effectiveness” of its finance function “in driving, measuring and reporting business performance”.

The deal covers over 50 countries, including the company’s headquarters in London and Sweden.